Dietary oxyresveratrol prevents parkinsonian mimetic 6-hydroxydopamine neurotoxicity
- 1 October 2008
- journal article
- Published by Elsevier BV in Free Radical Biology & Medicine
- Vol. 45 (7), 1019-1026
- https://doi.org/10.1016/j.freeradbiomed.2008.07.002
Abstract
No abstract availableThis publication has 67 references indexed in Scilit:
- Omega-3 Fatty Acids Supplementation Restores Mechanisms that Maintain Brain Homeostasis in Traumatic Brain InjuryJournal of Neurotrauma, 2007
- Neuroprotection and free radical scavenging effects of Osmanthus fragransJournal of Biomedical Science, 2007
- Dopamine depletion and subsequent treatment with l‐DOPA, but not the long‐lived dopamine agonist pergolide, enhances activity of the Akt pathway in the rat striatumJournal of Neurochemistry, 2007
- Oxyresveratrol dampens neuroimmune responses in vivo: a selective effect on TNF-αAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2006
- Beta-amyloid peptides induces neuronal apoptosis via a mechanism independent of unfolded protein responsesApoptosis, 2006
- Blood–brain barrier permeability to the neuroprotectant oxyresveratrolNeuroscience Letters, 2006
- Exogenous erythropoietin provides neuroprotection of grafted dopamine neurons in a rodent model of Parkinson's diseaseBrain Research, 2006
- Neuroprotective Effect of Oxyresveratrol from Smilacis Chinae Rhizome on Amyloid .BETA. Protein (25-35)-Induced Neurotoxicity in Cultured Rat Cortical NeuronsBiological & Pharmaceutical Bulletin, 2006
- Phosphorylation of p38 MAPK Induced by Oxidative Stress Is Linked to Activation of Both Caspase-8- and -9-mediated Apoptotic Pathways in Dopaminergic NeuronsJournal of Biological Chemistry, 2004
- Oxyresveratrol and Hydroxystilbene CompoundsPublished by Elsevier BV ,2002